257 related articles for article (PubMed ID: 15743508)
1. Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study.
Tokés AM; Kulka J; Paku S; Szik A; Páska C; Novák PK; Szilák L; Kiss A; Bögi K; Schaff Z
Breast Cancer Res; 2005; 7(2):R296-305. PubMed ID: 15743508
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of claudin-1 correlates with recurrence status in breast cancer.
Morohashi S; Kusumi T; Sato F; Odagiri H; Chiba H; Yoshihara S; Hakamada K; Sasaki M; Kijima H
Int J Mol Med; 2007 Aug; 20(2):139-43. PubMed ID: 17611630
[TBL] [Abstract][Full Text] [Related]
3. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
[TBL] [Abstract][Full Text] [Related]
4. Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma.
Dos Reis PP; Bharadwaj RR; Machado J; Macmillan C; Pintilie M; Sukhai MA; Perez-Ordonez B; Gullane P; Irish J; Kamel-Reid S
Cancer; 2008 Dec; 113(11):3169-80. PubMed ID: 18991282
[TBL] [Abstract][Full Text] [Related]
5. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
6. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
7. Expression analysis and study of KLK4 in benign and malignant breast tumours.
Papachristopoulou G; Avgeris M; Scorilas A
Thromb Haemost; 2009 Feb; 101(2):381-7. PubMed ID: 19190825
[TBL] [Abstract][Full Text] [Related]
8. Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells.
Hoevel T; Macek R; Mundigl O; Swisshelm K; Kubbies M
J Cell Physiol; 2002 Apr; 191(1):60-8. PubMed ID: 11920682
[TBL] [Abstract][Full Text] [Related]
9. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma.
Chao YC; Pan SH; Yang SC; Yu SL; Che TF; Lin CW; Tsai MS; Chang GC; Wu CH; Wu YY; Lee YC; Hong TM; Yang PC
Am J Respir Crit Care Med; 2009 Jan; 179(2):123-33. PubMed ID: 18787218
[TBL] [Abstract][Full Text] [Related]
10. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
11. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
[TBL] [Abstract][Full Text] [Related]
12. Claudin expression in breast cancer: high or low, what to expect?
Ricardo S; Gerhard R; Cameselle-Teijeiro JF; Schmitt F; Paredes J
Histol Histopathol; 2012 Oct; 27(10):1283-95. PubMed ID: 22936447
[TBL] [Abstract][Full Text] [Related]
13. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
14. Paracrine-stimulated gene expression profile favors estradiol production in breast tumors.
Amin SA; Huang CC; Reierstad S; Lin Z; Arbieva Z; Wiley E; Saborian H; Haynes B; Cotterill H; Dowsett M; Bulun SE
Mol Cell Endocrinol; 2006 Jul; 253(1-2):44-55. PubMed ID: 16735089
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease.
Kim TH; Huh JH; Lee S; Kang H; Kim GI; An HJ
Histopathology; 2008 Jul; 53(1):48-55. PubMed ID: 18479414
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of claudin 1, 3, and 4 during normal mammary gland development in the mouse.
Blanchard AA; Watson PH; Shiu RP; Leygue E; Nistor A; Wong P; Myal Y
DNA Cell Biol; 2006 Feb; 25(2):79-86. PubMed ID: 16460231
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast.
Cîmpean AM; Raica M; Nariţa D
Rom J Morphol Embryol; 2005; 46(2):123-9. PubMed ID: 16286998
[TBL] [Abstract][Full Text] [Related]
18. Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours.
Jakab C; Halász J; Szász AM; Kiss A; Schaff Z; Rusvai M; Gálfi P; Kulka J
J Comp Pathol; 2008 Nov; 139(4):238-45. PubMed ID: 18848337
[TBL] [Abstract][Full Text] [Related]
19. Claudin-16 reduces the aggressive behavior of human breast cancer cells.
Martin TA; Harrison GM; Watkins G; Jiang WG
J Cell Biochem; 2008 Sep; 105(1):41-52. PubMed ID: 18442037
[TBL] [Abstract][Full Text] [Related]
20. BigH3 protein expression as a marker for breast cancer.
Calaf GM; Echiburú-Chau C; Zhao YL; Hei TK
Int J Mol Med; 2008 May; 21(5):561-8. PubMed ID: 18425347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]